An elite scientific team developing new CAR T-cell gene therapy treatment for advanced metastatic prostate cancer at Abramson Cancer Center of the University of Pennsylvania received a $500,000 grant from Alliance for Cancer Care Therapy (ACGT). Specifically, Joseph...